Invention Grant
- Patent Title: Suspension formulations
- Patent Title (中): 悬浮剂
-
Application No.: US12865142Application Date: 2009-02-02
-
Publication No.: US09011923B2Publication Date: 2015-04-21
- Inventor: David Andrew Lewis , Christina Alexandra Keeble , Nicola Kim Whitfield , Tanya Church
- Applicant: David Andrew Lewis , Christina Alexandra Keeble , Nicola Kim Whitfield , Tanya Church
- Applicant Address: GB Edinburgh GB Wiltshire
- Assignee: Innovata Biomed Limited,Vectura Limited
- Current Assignee: Innovata Biomed Limited,Vectura Limited
- Current Assignee Address: GB Edinburgh GB Wiltshire
- Agency: LeClairRyan, a Professional Corporation
- Priority: GB0801876.4 20080201
- International Application: PCT/GB2009/000261 WO 20090202
- International Announcement: WO2009/095681 WO 20090806
- Main IPC: A61K9/50
- IPC: A61K9/50 ; A61K9/12 ; A61P11/08 ; A61P11/06 ; B29B9/16 ; A61K31/00 ; A61K31/167 ; A61K31/58 ; A61K9/00
Abstract:
The present invention relates to suspension formulations, especially those for delivering a pharmaceutically active agent in aerosol form using a spray or aerosol device, such as a pressurized metered dose inhaler (pMDI). The formulations may be for pulmonary, nasal, buccal or topical administration, but are preferably for pulmonary inhalation.
Public/Granted literature
- US20110182997A1 SUSPENSION FORMULATIONS Public/Granted day:2011-07-28
Information query
